Nifty

:

22147.00

Sensex

:

73088.33

151.15 (0.69%)
599.34 (0.83%)

Login

Nifty
Sensex

:
:

22147.00
73088.33

151.15 (0.69%)
599.34 (0.83%)

Vista Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

39/99

BSE: 524711 | NSE: Not Listed

Watchlist

NSE BSE

13.31

19-Apr-2024

Open
High
Low
Previous Close

14.20
14.20
13.30
14.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

29
0.41
19.70
7.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

66.59
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

75.60
N/A
1.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-19.07
-49.70
-7.66

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
20.80

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
41.21

P:E (Median)

8 Years
5 Years
3 Years

30.17
-
-

P:BV (Average)

8 Years
5 Years
3 Years

1.10
1.10
1.19

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-6.88
-24.11
-39.79

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 1.70 0.00 0 3.47 0.00 0 1.98 0.00 0 1.00 0.00 0
Expenses 3.45 0.34 914.71% 4.64 0.15 2,993.33% 2.90 0.20 1,350.00% 2.38 0.37 543.24%
EBITDA -1.75 -0.34 - -1.17 -0.15 - -0.92 -0.20 - -1.37 -0.37 -
EBIDTM -102.35% 0.00% -33.69% 0.00% -46.49% 0.00% -136.85% 0.00%
Other Income 0.02 0.00 0 0.08 0.00 0 0.13 0.00 0 0.29 0.30 -3.33%
Interest 0.30 0.40 -25.00% 0.32 0.26 23.08% 0.33 0.24 37.50% 0.32 0.29 10.34%
Depreciation 0.18 0.15 20.00% 0.18 0.15 20.00% 0.17 0.15 13.33% 1.11 0.15 640.00%
PBT -2.20 -0.89 - -1.59 -0.56 - -1.29 -0.59 - -2.52 -0.52 -
Tax -0.57 0.07 - 0.43 -0.32 - -0.33 0.00 - 1.35 -2.57 -
PAT -1.63 -0.96 - -2.02 -0.24 - -0.96 -0.59 - -3.87 2.05 -
PATM -95.54% 0.00% -58.18% 0.00% -48.21% 0.00% -385.16% 0.00%
EPS -0.35 -0.20 - -0.43 -0.05 - -0.20 -0.13 - -0.82 0.44 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 8.15 1.00 0.39 1.27 22.76 31.07 28.92 24.18 15.38 13.75 8.30 Net Sales Growth 0.00% 156.41% -69.29% -94.42% -26.75% 7.43% 19.60% 57.22% 11.85% 65.66% Cost Of Goods Sold 8.61 2.83 0.36 0.73 23.94 25.41 15.96 16.10 9.57 7.37 4.59 Gross Profit -0.46 -1.82 0.03 0.54 -1.18 5.66 12.96 8.08 5.81 6.37 3.71 GP Margin -5.62% -182.00% 7.69% 42.52% -5.18% 18.22% 44.81% 33.42% 37.78% 46.33% 44.70% Total Expenditure 13.37 5.45 1.66 3.00 27.56 29.84 23.58 21.13 12.78 11.04 7.08 Power & Fuel Cost - 0.23 0.22 0.28 0.39 0.46 0.70 0.50 0.36 0.52 0.49 % Of Sales - 23.00% 56.41% 22.05% 1.71% 1.48% 2.42% 2.07% 2.34% 3.78% 5.90% Employee Cost - 0.51 0.57 1.15 1.30 1.18 0.87 0.70 0.81 0.69 0.62 % Of Sales - 51.00% 146.15% 90.55% 5.71% 3.80% 3.01% 2.89% 5.27% 5.02% 7.47% Manufacturing Exp. - 0.28 0.07 0.14 0.44 0.39 0.93 0.43 0.81 1.10 0.84 % Of Sales - 28.00% 17.95% 11.02% 1.93% 1.26% 3.22% 1.78% 5.27% 8.00% 10.12% General & Admin Exp. - 0.53 0.30 0.66 1.10 0.82 1.10 0.62 0.65 0.60 0.40 % Of Sales - 53.00% 76.92% 51.97% 4.83% 2.64% 3.80% 2.56% 4.23% 4.36% 4.82% Selling & Distn. Exp. - 0.01 0.07 0.01 0.05 0.20 1.47 1.78 0.42 0.68 0.14 % Of Sales - 1.00% 17.95% 0.79% 0.22% 0.64% 5.08% 7.36% 2.73% 4.95% 1.69% Miscellaneous Exp. - 1.06 0.07 0.03 0.32 1.38 2.54 0.99 0.16 0.08 0.14 % Of Sales - 106.00% 17.95% 2.36% 1.41% 4.44% 8.78% 4.09% 1.04% 0.58% 0% EBITDA -5.21 -4.45 -1.27 -1.73 -4.80 1.23 5.34 3.05 2.60 2.71 1.22 EBITDA Margin -63.93% -445.00% -325.64% -136.22% -21.09% 3.96% 18.46% 12.61% 16.91% 19.71% 14.70% Other Income 0.52 0.40 0.17 0.20 3.75 2.95 0.40 0.06 0.02 0.01 0.03 Interest 1.27 1.21 0.90 1.55 1.54 1.67 1.57 0.88 0.77 0.41 0.00 Depreciation 1.64 0.62 0.62 0.73 1.35 1.36 1.34 1.02 1.02 1.05 0.77 PBT -7.60 -5.88 -2.62 -3.81 -3.94 1.15 2.83 1.22 0.84 1.26 0.47 Tax 0.88 -0.21 -1.73 -1.80 -0.26 0.21 0.64 -0.02 0.06 -0.11 0.01 Tax Rate -11.58% 3.57% 66.03% 47.24% 6.60% 18.26% 22.61% -1.64% 7.14% -8.73% 2.13% PAT -8.48 -5.66 -0.89 -2.01 -3.68 0.94 2.19 1.25 0.77 1.36 0.47 PAT before Minority Interest -8.48 -5.66 -0.89 -2.01 -3.68 0.94 2.19 1.25 0.77 1.36 0.47 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -104.05% -566.00% -228.21% -158.27% -16.17% 3.03% 7.57% 5.17% 5.01% 9.89% 5.66% PAT Growth -3,361.54% - - - - -57.08% 75.20% 62.34% -43.38% 189.36% EPS -1.81 -1.21 -0.19 -0.43 -0.78 0.20 0.47 0.27 0.16 0.29 0.10

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 36.71 35.45 32.85 29.64 35.80 31.86 16.61 11.21 10.44 9.09 Share Capital 7.51 7.36 7.36 6.07 6.07 5.83 5.31 5.00 5.00 15.00 Total Reserves 23.04 28.09 25.49 23.57 27.25 20.46 11.29 6.21 5.44 -5.91 Non-Current Liabilities 2.60 4.02 10.51 5.18 5.89 5.66 5.49 7.93 0.15 0.26 Secured Loans 5.18 7.43 8.69 5.51 5.96 5.88 6.03 7.88 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.06 0.07 0.07 0.05 0.05 0.06 0.05 0.05 0.04 0.04 Current Liabilities 14.08 12.64 9.25 15.92 10.95 15.20 18.93 7.24 12.19 4.70 Trade Payables 7.80 5.37 5.11 5.16 5.25 9.13 12.93 6.55 7.75 4.32 Other Current Liabilities 1.14 1.91 1.88 0.56 0.25 0.31 0.45 0.09 0.08 0.02 Short Term Borrowings 4.78 5.13 2.02 9.96 5.21 5.18 5.30 0.00 4.04 0.00 Short Term Provisions 0.36 0.24 0.24 0.24 0.24 0.58 0.25 0.60 0.33 0.36 Total Liabilities 53.39 52.11 52.61 50.74 52.64 52.72 41.03 26.38 22.78 14.05 Net Block 19.74 19.33 19.93 20.66 20.52 17.67 13.46 9.96 10.73 11.69 Gross Block 26.76 25.74 25.72 25.72 24.24 20.02 14.47 18.74 18.49 18.41 Accumulated Depreciation 7.02 6.41 5.79 5.06 3.71 2.35 1.02 8.78 7.77 6.72 Non Current Assets 29.64 28.55 37.37 29.56 29.19 24.88 15.52 10.04 10.80 11.77 Capital Work in Progress 9.33 9.08 9.08 8.78 8.54 7.11 1.99 0.00 0.00 0.00 Non Current Investment 0.02 0.03 0.04 0.02 0.03 0.02 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.43 0.00 0.10 0.10 0.10 0.08 0.07 0.08 0.08 0.08 Other Non Current Assets 0.13 0.10 8.22 0.00 0.00 0.00 0.01 0.00 0.00 0.00 Current Assets 23.75 23.56 15.24 21.19 23.45 27.84 25.50 16.34 11.97 2.29 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 7.68 9.33 9.68 9.68 11.25 10.91 8.14 2.68 0.22 0.69 Sundry Debtors 11.25 10.46 2.17 10.28 8.35 10.86 9.01 9.74 11.29 1.03 Cash & Bank 0.20 0.07 0.14 0.23 0.87 1.79 5.77 0.43 0.10 0.10 Other Current Assets 4.62 0.59 0.10 0.00 2.99 4.27 2.58 3.49 0.36 0.46 Short Term Loans & Adv. 4.62 3.11 3.15 1.00 1.18 2.38 2.50 0.02 0.07 0.00 Net Current Assets 9.67 10.92 5.99 5.26 12.50 12.64 6.57 9.10 -0.22 -2.41 Total Assets 53.39 52.11 52.61 50.75 52.64 52.72 41.02 26.38 22.77 14.06

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -1.71 -0.99 -6.75 0.80 3.30 -4.58 2.57 -2.50 -3.53 -0.09 PBT -5.88 -2.62 -3.69 -3.94 1.15 2.83 1.22 0.84 1.26 0.47 Adjustment 1.83 1.51 2.25 1.91 2.03 2.61 1.88 1.78 1.45 0.75 Changes in Working Capital 1.28 0.12 -5.31 2.83 0.50 -10.03 -0.52 -4.93 -6.24 -1.31 Cash after chg. in Working capital -2.76 -0.99 -6.75 0.80 3.68 -4.58 2.59 -2.32 -3.53 -0.09 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 -0.02 0.00 0.00 0.00 Tax Paid 1.05 0.00 0.00 0.00 -0.38 0.00 0.00 -0.18 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.27 -0.01 -0.30 -1.73 -5.65 -10.61 -3.61 -0.24 -0.09 0.01 Net Fixed Assets -1.27 -0.02 -0.30 -1.72 -5.65 -10.67 2.28 -0.25 -0.08 -0.02 Net Investments 0.01 0.01 -0.02 0.01 -0.01 -0.02 0.00 0.00 0.00 0.00 Others -0.01 0.00 0.02 -0.02 0.01 0.08 -5.89 0.01 -0.01 0.03 Cash from Financing Activity 3.11 0.94 6.96 0.28 1.43 11.22 6.36 3.07 3.63 0.00 Net Cash Inflow / Outflow 0.13 -0.07 -0.09 -0.64 -0.92 -3.98 5.32 0.34 0.00 -0.08 Opening Cash & Equivalents 0.07 0.14 0.23 0.87 1.79 5.77 0.45 0.10 0.10 0.18 Closing Cash & Equivalent 0.20 0.07 0.14 0.23 0.87 1.79 5.77 0.43 0.10 0.10

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 8.13 9.64 8.93 9.76 10.97 9.02 6.25 4.48 4.17 6.06 ROA -10.73% -1.70% -3.89% -7.11% 1.78% 4.67% 3.70% 3.15% 7.39% 3.27% ROE -17.16% -2.60% -6.43% -11.68% 3.15% 10.19% 8.97% 7.15% 13.94% 5.27% ROCE -9.85% -3.75% -5.10% -5.20% 6.28% 12.42% 8.92% 9.57% 14.16% 5.38% Fixed Asset Turnover 0.04 0.02 0.05 0.91 1.40 1.68 1.46 0.83 0.74 0.45 Receivable days 3948.36 5842.77 1794.10 149.36 112.81 125.43 141.56 249.65 163.68 45.48 Inventory Days 3091.84 8791.54 2790.39 167.81 130.14 120.26 81.65 34.39 12.15 44.79 Payable days 849.73 5212.95 2566.27 79.41 89.81 186.95 171.33 188.84 192.34 186.82 Cash Conversion Cycle 6190.47 9421.37 2018.22 237.77 153.14 58.73 51.87 95.20 -16.51 -96.54 Total Debt/Equity 0.33 0.35 0.33 0.52 0.34 0.42 0.68 0.70 0.39 0.00 Interest Cover -3.84 -1.91 -1.46 -1.56 1.69 2.79 2.40 2.09 4.05 154.33

Top Investors:

pavan sathvik gilaka

keshava murthy shiva shankar

deepthi pachipala

rajendar balakrishna

Annual Reports:

News Update:

Vista Pharma - Quarterly Results
10th Feb 2024, 17:53 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback